Nano Chemotherapy: An Emerging Anti-Cancer Modality
Efficacy of nanomedicine in oncology, increasing the prevalence of respiratory disorders, cancer and other diseases, the promising approach of reversible crosslinked nanocarriers in tumour treatment, potential to overcome the drug resistance, advent of next-generation cancer nanotherapeutics are the drivers of global nano chemotherapy market. However, delivery of the nanoparticle drugs into the clinics is quite a challenge.
According to Goldstein Research, Nano Chemotherapy Market size is set to reach USD 3.5 billion by 2024, at a CAGR of 7.45% over the forecast years owing to rising range of pipeline products and advent of nanotechnology in immunotherapy, hormone therapy, etc.
Geographically, US has the largest market for Nano Chemotherapy and acquires the market share of 75% of total North America nano chemotherapy market due to increasing research and development projects on nanotech implementation in therapeutics and other branches of healthcare.
Nanotechnology and its Medical Application
Biological processes especially the ones necessary for life lead to cancer, occur at the nanoscale level. In fact, we all are made up of a multitude of biological nano-machines. The domains of application of nanodevices: nanopores, dendrimers, nanotubes, quantum dots, nanoshells, etc while the area of application of nanotechnology comprises of cellular & molecular dynamics, molecular imaging improvement & early pathology detection, disease prevention & control and drug delivery & therapeutics. Because of various abilities, nano scale devices can have both targeting and therapeutic agents (in both single and multidrug approaches) and can deliver high drug levels in various situations.
Global Nano Chemotherapy Market Outlook
This report contains a detailed overview of the global nano chemotherapy market in terms of market segmentation by type, application and end user.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis.
Global Nano Chemotherapy market report also provides a competitive outlook for some of the major players which includes profiling of companies such as Ablynx, AMAG, Amgen, Celgene, CytImmune, Cornerstone, Delpor, Ensysce, MagForce, Merrimack, Nanotherapeutics, Nanobiotix, Nanospectra, Spectrum Pharmaceuticals, Tarveda. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments.
Overall, the report represents comprehensive synopsis on the global nano chemotherapy market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market-centric strategies according to the ongoing and expected trends in the future.
Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.
Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear-cut forecasts. Backed up by reliable research and impactful statistics, our business solutions empower our clients to grow at a fast pace despite unsettling fluctuations in the market. We believe in a vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.